Data/Analytics Blogs

09|17|19

Intouch Takes Data Security to the Next Level With Two New, Highly Regarded Credentials

Data breaches have become so common, there’s a Wikipedia page devoted to cataloging them – to date, more than 300 breaches are listed. Types of industries affected include hospitality, travel, internet service providers, banking, social media, retail, and of course, healthcare, among others. The massive Equifax breach announced in September 2017 led the Federal Trade […]

07|16|19

Six Ways Data Science Can Create More Efficient Marketing Experiences

Data science: a term that always sounds cutting-edge. While discussions of personalized medicine and the related science of gene therapy and similar advances become more science than science fiction, pharma marketing is beginning to step into the individualized, independent experience economy, as well. What is the experience economy? It’s not just the product or service […]

03|26|19

The Pressing Need for Data Reformation

Each year, Intouch heads to South by Southwest to talk to experts, share insights, and get inspired by the most creative minds in the world. On the ground, we debrief, connect the dots, and distill our findings to the themes and actions that will mean the most to our teams and clients. Here’s the second […]

12|06|18

GDPR, AI and Machine Learning in the Age of Data Privacy

As of May 2018, the implementation of the General Data Protection Regulation (GDPR) allows European consumers more “ownership” of their data and the ability to remove that data from marketing systems. This POV from Intouch innovation manager Andrew Grojean will answer these questions and provide recommendations for marketers leveraging AI in the new age of data privacy and security.

09|19|18

Should Pharma Care About California’s New Data Privacy Law?

Concerns about data privacy abound as we head into the final quarter of 2018. In this Intouch POV, we discuss the CCPA, what it entails, how pharma marketers might be affected, and what they can do to prepare for the law’s 2020 implementation.

03|29|18

Cambridge Analytica Scandal: Don’t Blame Facebook. Blame Bad Ethics

This POV breaks down the Cambridge Analytica scandal, clarifies what pertains to pharma marketers, and lays out recommendations in light of the news.

01|08|18

The Data Will See You Now: Welcome to the Future of Healthcare

From how we manage our own health, to the job of a physician, to the managed care industry, the surfeit of data has changed everything. And pharmaceutical marketing is no exception. In this POV, we investigate these seismic shifts driven by the omnipresence of data, the macro and micro trends that pharma marketers need to know, and how to apply the knowledge to stay ahead.

02|08|17

Brave New World, Brave New Metrics: Why Engagement Analytics Matter in Value-Based Care

EXECUTIVE SUMMARYA good product alone doesn’t always guarantee success. Today, marketers need to understand that successfully engaging with customers means providing helpful information, even if it doesn’t result in an immediate sale. This is true whether you’re offering consumer-packaged goods in retail stores or a new treatment option for healthcare professionals. Value-based care has been […]

04|15|15

Twitter Taps Big Data to Provide Better Ad Targeting

TWITTER TAPS BIG DATA TO PROVIDE BETTER AD TARGETING EXECUTIVE SUMMARY On March 5, 2015, Twitter announced a new ad targeting feature called “partner audiences.” Twitter has partnered with third-party big data providers Datalogix and Acxiom to enhance targeting and give advertisers new options for reaching a more qualified audience based on purchase behavior data. […]